ELAN Corporation Q2 FY2025 earnings call

Overall Financial Results

• The company achieved year-over-year revenue growth of 17.5% and operating profit growth of 7.5%. The revenue growth was driven by an increase in new contracted clients for the CS Set product and contributions from two recently acquired Vietnamese subsidiaries.
• Operating profit growth was slower than revenue growth due to higher-than-expected one-off depreciation costs from stronger-than-projected adoption of the original patient gown product Lifte, which reached 113 facility adoptions in the first half of the fiscal year.

Core Business Metrics

• Total contracted facilities reached 2,691, a 10.3% year-over-year increase. The cumulative first-half churn rate fell slightly to 3.7%, showing early results from the company's prioritized churn reduction initiatives, which will remain a key focus going forward.
• Monthly active users reached 466,069, a 7.2% year-over-year increase. The slower growth rate compared to facility growth is due to the trend of new contracted facilities being mostly small-scale (under 50 beds) long-term care facilities, which aligns with broader industry growth of small senior living facilities.
• 65% of churn is client outflow to competitors, while 35% comes from facility closure or consolidation.

New Products and Services

• The new clothing service for care facilities, SmileWear, launched national rollout after a pilot period, and is now operational at 24 facilities including medical institutions. The service addresses customer demand for brighter, more comfortable clothing for care facility residents and reduces administrative burden for staff and families.
• High-value add-on services for the core CS Set line (CS Set R and CS Set LC) have grown steadily to 339 and 263 adopted facilities respectively, driven by demand for guarantor support and customer harassment mitigation. Original patient gown Lifte continues to see accelerating adoption growth.

Collaboration and Subsidiary Updates

• As part of the M3 Group, Elan has launched joint sales proposals to shared medical facility clients in the first half, speeding up CS Set adoption timelines. Leveraging group purchasing power has also delivered cost reductions.
• A differentiated CS Set product co-developed with M3 Group is on track to launch in the second half of the fiscal year. The two companies will continue collaborating on new overseas business expansion.
• Elan's spun-off domestic subsidiaries (Elan Service, Elan Logistics, Elan Creer) currently primarily serve Elan's core business, and will target external sales growth going forward.

Vietnam segment (consolidating GREEN Corp and TMC Corp): The segment includes 80 million yen in goodwill amortization expense, and still maintains operating profit. Excluding goodwill amortization expense, the Vietnam segment's operating profit margin reaches 20.6%. No absolute revenue figures or revenue contribution percentages for other segments are provided in the available transcript.

• The full-year 2025 December fiscal year consolidated earnings guidance and dividend forecast are maintained at prior levels, with no revision from previous announcements. The 2023-2025 mid-term management vision also remains unchanged.
• The company is currently developing a new long-term vision and next mid-term management plan, which will be publicly announced by the full-year 2025 December fiscal year earnings release.
• Elan Logistics targets expanding its delivery facility network to 450 facilities by the end of the 2025 fiscal year, up from the current 406 facilities.

• The company has faced slower-than-planned new client acquisition for the core CS Set product and slower-than-projected launch of new businesses in the first half.
• First half costs for Lifte adoption reached 600 million yen, compared to a planned budget of 400 million yen due to higher-than-expected demand, which reduced first half operating profit.
• Industry trends have shifted to growth of small-scale care facilities, which deliver lower per-facility revenue compared to the historical large/medium facility client base.

Only a partial question for one exchange is available in the provided transcript, no full Q&A content is accessible.

Q: The core of Elan's business is short-term contracts that end when patients are discharged from the hospital. What initiatives is the company pursuing to extend average contract duration via post-discharge and at-home services? / A: No answer is included in the available transcript.